Nuveen Asset Management, LLC Vericel Corp Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Vericel Corp stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 519,727 shares of VCEL stock, worth $23.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

519,727

Previous 606,904 14.36%

Holding current value

$23.3 Million

Previous $21.6 Million 25.1%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$32.52 - $52.33 $2.83 Million - $4.56 Million	-87,177 Reduced 14.36%	519,727 $27 Million
Q4 2023 Feb 14, 2024	BUY	$30.85 - $37.09 $138,794 - $166,867	4,499 Added 0.75%	606,904 $21.6 Million
Q3 2023 Nov 14, 2023	BUY	$31.69 - $39.25 $6.5 Million - $8.05 Million	205,014 Added 51.59%	602,405 $20.2 Million
Q2 2023 Aug 14, 2023	BUY	$29.0 - $38.37 $7.88 Million - $10.4 Million	271,727 Added 216.23%	397,391 $14.9 Million
Q1 2023 May 15, 2023	SELL	$23.85 - $31.34 $595,129 - $782,027	-24,953 Reduced 16.57%	125,664 $3.68 Million

Q4 2022 Feb 14, 2023	SELL	$17.65 - $27.37 $695,921 - $1.08 Million	-39,429 Reduced 20.75%	150,617 $3.97 Million
Q3 2022 Nov 14, 2022	SELL	$22.62 - $32.54 $172,613 - $248,312	-7,631 Reduced 3.86%	190,046 $4.41 Million
Q2 2022 Aug 15, 2022	BUY	$22.88 - $39.45 $121,675 - $209,795	5,318 Added 2.76%	197,677 $4.98 Million
Q1 2022 May 16, 2022	SELL	$31.69 - $43.29 $238,720 - $326,103	-7,533 Reduced 3.77%	192,359 $6.35 Million
Q4 2021 Feb 14, 2022	SELL	$35.2 - $52.6 $4.48 Million - $6.7 Million	-127,400 Reduced 38.93%	199,892 $7.04 Million
Q3 2021 Nov 12, 2021	SELL	$46.35 - $59.75 $1.71 Million - $2.21 Million	-36,927 Reduced 10.14%	327,292 $16.9 Million
Q2 2021 Aug 16, 2021	SELL	$47.2 - $67.81 $1.82 Million - $2.61 Million	-38,561 Reduced 9.57%	364,219 $19.1 Million
Q1 2021 May 17, 2021	BUY	$30.93 - $59.48 $814,386 - $1.57 Million	26,330 Added 6.99%	402,780 $22.4 Million
Q4 2020 Feb 16, 2021	BUY	$18.53 - $31.5 $2.06 Million - $3.5 Million	111,045 Added 41.84%	376,450 $11.6 Million
Q3 2020 Nov 16, 2020	SELL	$14.68 - $19.12 $113,623 - $147,988	-7,740 Reduced 2.83%	265,405 $4.92 Million
Q2 2020 Aug 14, 2020	SELL	$8.5 - $15.82 $4.34 Million - $8.08 Million	-510,598 Reduced 65.15%	273,145 $3.78 Million
Q1 2020 May 14, 2020	BUY	$7.25 - $19.22 $179,930 - $477,001	24,818 Added 3.27%	783,743 $7.19 Million
Q4 2019 Feb 14, 2020	SELL	$13.77 - $19.2 $30,114 - $41,990	-2,187 Reduced 0.29%	758,925 $13.2 Million
Q3 2019 Nov 14, 2019	SELL	$14.93 - $19.83 $1.4 Million - $1.86 Million	-93,917 Reduced 10.98%	761,112 $11.5 Million
Q2 2019 Aug 15, 2019	BUY	$15.01 - $18.89 $12.8 Million - $16.2 Million	855,029 New	855,029 $16.2 Million

Others Institutions Holding VCEL

# of Institutions

263

Shares Held

48.9M

Call Options Held

150K

Put Options Held

128K

View Full List

About Vericel Corp

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.12B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

More about VCEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Vericel Corp Transaction History